Backgrounds/Aims: The superiority of anatomical resection (AR) for a small HCC remains controversial. In this study, we investigated the clinical outcomes after AR and non-anatomical liver resection (NAR) for single HCC smaller than 3 cm and the risk factors for HCC recurrence. Methods: A total of 116 consecutive patients who underwent liver resection for single HCC (＜3 cm) between Jan 2006 and Dec 2015 were included in this study. The medical records of these patients were reviewed and analyzed retrospectively. Results: There was no significant difference in tumor recurrence and survival between AR and NAR group. Multivariate analysis showed that hepatitis B (p=0.035, HR=8.72), presence of satellite nodule (p=0.029, HR=3.97) and microvascular invasion (MVI) (p=0.039, HR=2.79) were independent risk factors for early recurrence within 1 year. The overall recurrence was independently related to the presence of satellite nodule (p=0.001, HR=4.98) and background liver cirrhosis (p=0.032, HR=1.96). In patients with MVI, HCC recurrence was significantly more frequent in width of safety margin ＜1 cm group than ≥1 cm group (p=0.049). Conclusions: The outcomes of NAR are comparable with those of AR in single HCC smaller than 3 cm. The presence of satellite nodule, MVI and hepatitis B are the independent risk factors for early recurrence, however overall recurrence is correlated with background liver cirrhosis and the presence of satellite nodule rather than pathobiologic factors in single HCC smaller than 3 cm. Hepatic resection with sufficient margin (≥1 cm) is recommended for decreasing risk of recurrence in patients with suspected MVI. (Ann Hepatobiliary Pancreat Surg 2018;22:326-334)
INTRODUCTION
With the advance in imaging technologies and improved HCC surveillance, the incidence of early stage tumor has been improved gradually and effective treatment of early stage HCC has become increasingly important. 1 Although HCC surveillance and advance in treatment technologies have led to improved patient survival, the rate of recurrence is still high. Hepatic resection (HR) and radiofrequency ablation (RFA) are now widely used to treat patients with early stage HCC. Although it remains debatable which treatment has superiority over other, HR has been regarded as the first-line treatment for patients with early stage HCC and preserved hepatic function due to its acceptable mortality, morbidity and long-term outcomes. [2] [3] [4] Anatomical resection (AR) is defined as resection of the tumor including tumor-bearing portal vein territories. 5 Theoretically, HCC has a high propensity to invade the intrahepatic vascular structures and spreads mainly through the portal venous system rather than by adjacent diffusion; [6] [7] [8] thus, AR is regarded as effective treatment to avoid intrahepatic metastasis and recurrence. However, AR needs to sacrifice a large amount of liver parenchyma and is therefore significantly unfavorable for treating a liver that has an underlying disease. On the contrary, non-anatomical resection (NAR) is the conventional limited resection focused on achieving a non-tumoral liver parenchyma rim, without consideration of the Glisson's pedicles. 9, 10 While some studies have reported the superi-ority of AR over NAR, [10] [11] [12] [13] other studies have shown no prognostic difference between AR and NAR, 8, 14, 15 and some meta-analyses have also reported conflicting conclusions. [16] [17] [18] Therefore, the ideal treatment for HCC remains debatable.
A Japanese nationwide study demonstrated that AR is only beneficial for HCC of 2 to 5 cm, and not for very small HCC less than 2 cm. 19 
MATERIALS AND METHODS

RESULTS
Comparison of demographics and clinicopathologic features between resection groups
The demographics and clinical features of the 116 patients are summarized in Table 1 . Among these patients 92 patients were male (79.3%) and 24 patients were female (20.7%). The mean age of patients was 56.4 years.
All of these patients were classified as Child-Pugh A in 1A ) and recurrence-free survival rates were 84, 63 and 47%, respectively (Fig. 1B) .
In comparison of the clinicopathologic characteristics between AR and NAR group, there was no significant differences in demographics and pathologic findings except tumor location (Table 1 and 2). The 1-, 3-and 5-year overall survival rates were 100, 88 and 81% in AR group, and 98, 95 and 86% in NAR group, respectively ( Fig.   2A ). There was no significant difference in overall survival between AR and NAR group (p=0.78). The 1-, 3-and 5-year recurrence-free survival rates were 75, 56 and 43%
in AR group, and 90, 70 and 51% in NAR group, respectively (Fig. 2B ). There was also no significant difference in recurrence-free survival between AR and NAR group (p=0.455).
Although there was no significant difference between groups in recurrence time and pattern, tumor recurrences within 1 year after resection were more frequent in AR (Table 5) .
Relation between safety margin, microvascular invasion and recurrence
In terms of recurrence, width of safety margin (margin ＜1 cm) was not correlated with HCC recurrence after surgery in single HCC smaller than 3 cm (Fig. 3A) .
Although MVI was the independent prognostic factors for early recurrence (within 1 year), overall recurrence was not significantly affected by MVI (Fig. 3B) . However, time of recurrence was significantly different in patients with MVI according to the width of safety margin (＜1 cm vs ≥1 cm, p=0.049), on the other hand, there was no difference in patients without MVI according to the width of safety margin (Fig. 3C) . 
DISCUSSION
Liver resection has been accepted as the gold standard treatment for solitary HCC in patients with well-preserved liver function. 22 However, the superiority of AR has been still controversial. Recently, with the technical improvement, laparoscopic liver resection has been widely applied for the treatment of HCC and NAR can be performed more easily than AR with laparoscopy especially in cases of small HCC which is protruded or located peripherally.
For this reason, the proportion of laparoscopic resection was significantly higher in NAR group than AR group in this study.
Previously several retrospective studies reported the superiority of AR for HCC in the aspect of recurrence and survival. 9, [11] [12] [13] 23 However, most of these studies have significant selection bias of patients, the difference of reserved liver function which is a significant postoperative Our results showed that the outcomes of NAR in terms of recurrence pattern, recurrence-free survival, and overall survival were not different from those in AR (Table 3 , and multiple HCC. However, several studies reported that MVI had no significant impact on overall survival in patients with early HCC, whereas MVI had significant impact on recurrence. 19, 28, 29 These data correlate with our results up to a point. Our results showed that MVI was not correlated with overall recurrence and survival, while early recurrence (within 1 year) was significantly affected by MVI. In our data, background liver cirrhosis had more significant impact on overall survival along with the presence of satellite nodule rather than MVI and viral activity.
These results suggest that the prognosis after resection can be more affected by underlying liver status rather than pathobiological factors of tumor in early stage HCC, an observation supported by previous study which reported the importance of liver status as an independent prognostic factor predicting recurrence after resection. 8, 15, 30 The significance of safety margin in recurrence and survival after liver resection for HCC remains controversial.
Several studies reported no relation between the safety margin and prognosis, 8, [31] [32] [33] while other studies suggested that safety margin less than 1 cm had an negative effect on long-term prognosis. [34] [35] [36] Our data suggested that the width of safety margin has no impact on survival and 
